These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 273716)

  • 1. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R
    Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiotoxic aspects of daunorubicin used in the treatment of acute myeloblastic and lymphoblastic leukoses].
    Topalov V; Popović K; Cikos J; Pejin D; Uzurov V
    Med Pregl; 1981; 34(3-4):119-22. PubMed ID: 6944597
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of daunomycin in the treatment of acute leukemia in children].
    Massimo L
    Minerva Med; 1972 Mar; 63(24):1430-5. PubMed ID: 4502505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rubidomycin in acute leukemia in children].
    Armata J; Cyklis R; Garwicz S; Halikowski B; Wyszkowski J
    Pediatr Pol; 1969 Oct; 44(11):1405-12. PubMed ID: 5261217
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use of daunomycin in the therapy of acute leukemias].
    Tura S; Baccarani M; Storti EF
    Minerva Med; 1969 Jul; 60(56):2810-20. PubMed ID: 5257049
    [No Abstract]   [Full Text] [Related]  

  • 6. Early onset of daunomycin cardiotoxicity in a case of acute myelogeneous leukemia associated with Sweet's syndrome.
    Imamura N; Miura K; Kuramoto A
    Hiroshima J Med Sci; 1985 Jun; 34(2):253-6. PubMed ID: 3861598
    [No Abstract]   [Full Text] [Related]  

  • 7. Daunomycin treatment in acute leukemia.
    Holland JF
    Pathol Biol; 1967 Oct; 15(19):929-32. PubMed ID: 4869768
    [No Abstract]   [Full Text] [Related]  

  • 8. [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P].
    Bernard J; Jacquillat C; Boiron M; Weil M; Gémon MF; Izrael V; Schaison G; Delobel J
    Nouv Presse Med; 1972 Sep; 1(33):2149-52. PubMed ID: 4507740
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac ultrastructural changes induced by daunorubicin therapy.
    Buja LM; Ferrans VJ; Mayer RJ; Roberts WC; Henderson ES
    Cancer; 1973 Oct; 32(4):771-88. PubMed ID: 4270890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined treatment of acute leukemia with L-asparaginase and daunomycin].
    Gerhartz H
    Haematol Lat; 1969; 12(3):821-7. PubMed ID: 5273188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial of adriamycin in the treatment of acute leukemia].
    Mathé G; Amiel JL; Hayat M; de Vassal F; Schwarzenberg L; Schneider M; Jasmin C; Rosenfeld C
    Presse Med (1893); 1970 Oct; 78(46):1997-9. PubMed ID: 5274058
    [No Abstract]   [Full Text] [Related]  

  • 12. Daunorubicin (NSC-83142) in advanced childhood leukemia.
    Jaffe N; Traggis DG; Das L
    Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
    [No Abstract]   [Full Text] [Related]  

  • 13. Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
    Massimo L; Fossati-Guglielmoni A; Fortuna E
    Helv Paediatr Acta; 1968 Aug; 23(4):315-33. PubMed ID: 4300437
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia.
    Holton CP; Vietti TJ; Nora AH; Donaldson MH; Stuckey WJ; Watkins WL; Lane DM
    N Engl J Med; 1969 Jan; 280(4):171-4. PubMed ID: 5248383
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia.
    Goemans BF; Zwaan CM; Reinhardt D; Gibson BE; Hählen K; Kaspers GJ
    Haematologica; 2006 Nov; 91(11):1573-4. PubMed ID: 17043024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time relationship between last dose of daunorubicin and congestive heart failure.
    Von Hoff DD; Layard M; Rozencweig M; Muggia FM
    Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the use of daunomycin in acute leukemias in childhood].
    Esposito L
    Pediatria (Napoli); 1969; 77(5):739-50. PubMed ID: 4927376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trial of daunomycin in acute leukemia in adults].
    Martelli MF; Tonato M; Soldani M; Grignani F
    Clin Ter; 1972 Jan; 60(2):149-58. PubMed ID: 4501941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.